recombinant West Nile virus E DIII protein (Agency For Science Technology & Research/Duke-NUS Graduate Medical School)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namerecombinant West Nile virus E DIII protein (Agency For Science Technology & Research/Duke-NUS Graduate Medical School)
Drug Alias Namerecombinant West Nile virus E DIII protein (Agency For Science Technology & Research)West Nile virus vaccine (Agency For Science Technology & Research)
ClassificationBiologics > Protein drugs > Recombinant proteinVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Therapeutic vaccine +[5] 
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsWest Nile Fever
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingapore
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDuke-Nus Medical School
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAccelerate Technologies Pte LtdDuke-Nus Medical SchoolThe Agency for Science Technology and Research
Active IndicationsN/A
Inactive IndicationsWest Nile Fever

Other Information

ATC CodeN/A
Related LinksN/A